Monitoring Inflammatory Bowel Disease in Pregnancy Using Gastrointestinal UltrasonographyEmma Flanagan, Sally Bell, Emily K. Wright et al.|Journal of Crohn s and Colitis|2020Cited by 62
Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In UteroRalley Prentice, Sally Bell, Miles Sparrow et al.|Clinical Gastroenterology and Hepatology|2024Cited by 23
Reliability of Intestinal Ultrasound for Evaluating Crohn’s Disease Activity Using Point-of-care and Central ReadingThomas M Goodsall, Robert V. Bryant, Yoon‐Kyo An et al.|Clinical Gastroenterology and Hepatology|2024Cited by 22
Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn’s Disease Therapeutic Outcomes Assessed Clinically and EndoscopicallyEmily K. Wright, Thierry Dervieux|Journal of Crohn s and Colitis|2023Cited by 16
P614 Reduction of bowel wall thickness and doppler signals as early as 36 hours predicts corticosteroid response in a multi-centre prospective cohort of Acute Severe Ulcerative Colitis: USUC Study including the GENIUS cohortYoon‐Kyo An, Richard Fernandes, Niamh Lindsay et al.|Journal of Crohn s and Colitis|2023Cited by 3